nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR2C—Signaling Pathways—E2F1—ocular cancer	0.000482	0.000482	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—TP53—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—HRAS—ocular cancer	0.000477	0.000477	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TGFB1—ocular cancer	0.000474	0.000474	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—E2F1—ocular cancer	0.000469	0.000469	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CDKN1B—ocular cancer	0.000468	0.000468	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN2B—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Lisuride—DRD5—GPCR downstream signaling—AKT1—ocular cancer	0.000463	0.000463	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HDAC1—ocular cancer	0.000463	0.000463	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—E2F1—ocular cancer	0.000462	0.000462	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—HRAS—ocular cancer	0.000459	0.000459	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN2B—ocular cancer	0.000457	0.000457	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CCND1—ocular cancer	0.000447	0.000447	CbGpPWpGaD
Lisuride—ADRA2B—Hemostasis—AKT1—ocular cancer	0.000434	0.000434	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CDKN1A—ocular cancer	0.000432	0.000432	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GNA11—ocular cancer	0.000431	0.000431	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—E2F1—ocular cancer	0.000426	0.000426	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—AKT1—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—E2F1—ocular cancer	0.000419	0.000419	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN2B—ocular cancer	0.000415	0.000415	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—EP300—ocular cancer	0.000411	0.000411	CbGpPWpGaD
Lisuride—ADRA2C—Hemostasis—AKT1—ocular cancer	0.000405	0.000405	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000401	0.000401	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MDM2—ocular cancer	0.000393	0.000393	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—TP53—ocular cancer	0.00039	0.00039	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MDM2—ocular cancer	0.000385	0.000385	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—E2F1—ocular cancer	0.000381	0.000381	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MDM2—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—HRAS—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—HRAS—ocular cancer	0.000365	0.000365	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MDM2—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CDKN1B—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MYC—ocular cancer	0.000358	0.000358	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TGFB1—ocular cancer	0.000358	0.000358	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—HRAS—ocular cancer	0.000357	0.000357	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—AKT1—ocular cancer	0.000355	0.000355	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—HRAS—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CDKN1B—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—AKT1—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CDKN1B—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CCND1—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—AKT1—ocular cancer	0.000342	0.000342	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MDM2—ocular cancer	0.000341	0.000341	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MDM2—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MDM2—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—HRAS—ocular cancer	0.000336	0.000336	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCND1—ocular cancer	0.000335	0.000335	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CDKN1A—ocular cancer	0.000331	0.000331	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CDKN1B—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCND1—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—AKT1—ocular cancer	0.000329	0.000329	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—AKT1—ocular cancer	0.000326	0.000326	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CDKN1A—ocular cancer	0.000324	0.000324	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—AKT1—ocular cancer	0.000322	0.000322	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CDKN1A—ocular cancer	0.000319	0.000319	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—HRAS—ocular cancer	0.000317	0.000317	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—AKT1—ocular cancer	0.000316	0.000316	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—EP300—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCND1—ocular cancer	0.000315	0.000315	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—HRAS—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—HRAS—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CDKN1B—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—AKT1—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—EP300—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—AKT1—ocular cancer	0.000308	0.000308	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CDKN1B—ocular cancer	0.000307	0.000307	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CDKN1B—ocular cancer	0.000307	0.000307	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MDM2—ocular cancer	0.000306	0.000306	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CDKN1A—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—AKT1—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—AKT1—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MDM2—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—EP300—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCND1—ocular cancer	0.000297	0.000297	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—AKT1—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—TP53—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MDM2—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCND1—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCND1—ocular cancer	0.000293	0.000293	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MDM2—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—EP300—ocular cancer	0.00029	0.00029	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CDKN1A—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—HRAS—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MDM2—ocular cancer	0.000284	0.000284	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CDKN1A—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CDKN1A—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—HRAS—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GNA11—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—HRAS—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDKN1B—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—AKT1—ocular cancer	0.00028	0.00028	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MDM2—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDKN1B—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—AKT1—ocular cancer	0.000277	0.000277	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—AKT1—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MYC—ocular cancer	0.000275	0.000275	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—AKT1—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TGFB1—ocular cancer	0.000274	0.000274	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—EP300—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—HRAS—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—EP300—ocular cancer	0.000272	0.000272	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—HRAS—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—EP300—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—EP300—ocular cancer	0.00027	0.00027	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MYC—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TGFB1—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDKN1B—ocular cancer	0.000268	0.000268	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCND1—ocular cancer	0.000267	0.000267	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDKN1B—ocular cancer	0.000266	0.000266	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—AKT1—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MYC—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCND1—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TGFB1—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—HRAS—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—AKT1—ocular cancer	0.000263	0.000263	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000262	0.000262	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—HRAS—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDKN1B—ocular cancer	0.000259	0.000259	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CDKN1A—ocular cancer	0.000258	0.000258	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MDM2—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—AKT1—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CDKN1A—ocular cancer	0.000256	0.000256	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCND1—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDKN1B—ocular cancer	0.000255	0.000255	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCND1—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MDM2—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MYC—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—AKT1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TGFB1—ocular cancer	0.000252	0.000252	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—AKT1—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—AKT1—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—AKT1—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCND1—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CDKN1A—ocular cancer	0.000247	0.000247	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CDKN1A—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—EP300—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—EP300—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCND1—ocular cancer	0.000243	0.000243	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—AKT1—ocular cancer	0.00024	0.00024	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—HRAS—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CDKN1A—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MYC—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TGFB1—ocular cancer	0.000238	0.000238	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—HRAS—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CDKN1A—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—EP300—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MYC—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN1B—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MYC—ocular cancer	0.000235	0.000235	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TGFB1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TGFB1—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—EP300—ocular cancer	0.000234	0.000234	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—AKT1—ocular cancer	0.000233	0.000233	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—AKT1—ocular cancer	0.000232	0.000232	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN1B—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MDM2—ocular cancer	0.00023	0.00023	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—AKT1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—AKT1—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—EP300—ocular cancer	0.000227	0.000227	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—TP53—ocular cancer	0.000225	0.000225	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCND1—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—EP300—ocular cancer	0.000224	0.000224	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—EP300—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—TP53—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCND1—ocular cancer	0.000221	0.000221	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—TP53—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CDKN1A—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—HRAS—ocular cancer	0.000216	0.000216	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MYC—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—HRAS—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TGFB1—ocular cancer	0.000214	0.000214	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CDKN1A—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MYC—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TGFB1—ocular cancer	0.000212	0.000212	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—HRAS—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—AKT1—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN1B—ocular cancer	0.00021	0.00021	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—AKT1—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—HRAS—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—AKT1—ocular cancer	0.000208	0.000208	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—TP53—ocular cancer	0.000207	0.000207	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—EP300—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MYC—ocular cancer	0.000205	0.000205	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TGFB1—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MYC—ocular cancer	0.000204	0.000204	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TGFB1—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—EP300—ocular cancer	0.000203	0.000203	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCND1—ocular cancer	0.000201	0.000201	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—HRAS—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MYC—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TGFB1—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—TP53—ocular cancer	0.000196	0.000196	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MYC—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TGFB1—ocular cancer	0.000195	0.000195	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CDKN1A—ocular cancer	0.000194	0.000194	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—TP53—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—TP53—ocular cancer	0.000193	0.000193	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—AKT1—ocular cancer	0.00019	0.00019	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—AKT1—ocular cancer	0.000189	0.000189	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—HRAS—ocular cancer	0.000187	0.000187	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—AKT1—ocular cancer	0.000186	0.000186	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—EP300—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—HRAS—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—AKT1—ocular cancer	0.000183	0.000183	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MYC—ocular cancer	0.00018	0.00018	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TGFB1—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MYC—ocular cancer	0.000177	0.000177	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TGFB1—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—TP53—ocular cancer	0.000176	0.000176	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—AKT1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—TP53—ocular cancer	0.000174	0.000174	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—TP53—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—HRAS—ocular cancer	0.000168	0.000168	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—TP53—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—HRAS—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—AKT1—ocular cancer	0.000165	0.000165	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—AKT1—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—AKT1—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—TP53—ocular cancer	0.000163	0.000163	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MYC—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—HRAS—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TGFB1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—TP53—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—HRAS—ocular cancer	0.00016	0.00016	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—HRAS—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—HRAS—ocular cancer	0.000153	0.000153	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—AKT1—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TP53—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—AKT1—ocular cancer	0.000147	0.000147	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TP53—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—EP300—ocular cancer	0.000144	0.000144	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—AKT1—ocular cancer	0.000142	0.000142	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—AKT1—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—HRAS—ocular cancer	0.000141	0.000141	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—HRAS—ocular cancer	0.000139	0.000139	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—AKT1—ocular cancer	0.000137	0.000137	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—AKT1—ocular cancer	0.000135	0.000135	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—AKT1—ocular cancer	0.000133	0.000133	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TP53—ocular cancer	0.000132	0.000132	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—HRAS—ocular cancer	0.000126	0.000126	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—AKT1—ocular cancer	0.000125	0.000125	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—AKT1—ocular cancer	0.000123	0.000123	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—AKT1—ocular cancer	0.000112	0.000112	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—EP300—ocular cancer	9.41e-05	9.41e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—AKT1—ocular cancer	8.7e-05	8.7e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—AKT1—ocular cancer	5.69e-05	5.69e-05	CbGpPWpGaD
